Company MetaStat, Inc. Other OTC
Equities
MTST
US59140A2033
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Novel Diagnostics
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/14 | |
Frederick Pierce
IRC | Investor Relations Contact | 63 | 28/02/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/14 | |
Paul Billings
BRD | Director/Board Member | 71 | 23/05/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 279,904 | 0 | 0 | 98.43 % |
Stock B | 1 | 5,877,383 | 5,785,202 ( 98.43 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+49.41% | 56.95B | |
+39.50% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
+25.18% | 12.21B | |
-0.08% | 12.15B |